The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Plant‐made vaccines for humans and animals
Open accessAbstract
Summary: The concept of using plants to produce high‐value pharmaceuticals such as vaccines is 20 years old this year and is only now on the brink of realisation as an established technology. The original reliance on transgenic plants has largely given way to transient expression; proofs of concept for human and animal vaccines and of efficacy for animal vaccines have been established; several plant‐produced vaccines have been through Phase I clinical trials in humans and more are scheduled; regulatory requirements are more clear than ever, and more facilities exist for manufacture of clinic‐grade materials. The original concept of cheap edible vaccines has given way to a realisation that formulated products are required, which may well be injectable. The technology has proven its worth as a means of cheap, easily scalable production of materials: it now needs to find its niche in competition with established technologies. The realised achievements in the field as well as promising new developments will be reviewed, such as rapid‐response vaccines for emerging viruses with pandemic potential and bioterror agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Production of antibodies in transgenic plants
Hiatt, A., Caffferkey, R., & Bowdish, K. (1989) · Nature · doi:10.1038/342076a0 · Cited by 1,059
Plant-based production of biopharmaceuticals
Fischer, R., Stoger, E., Schillberg, S., Christou, P., & Twyman, R. M. (2004) · Current Opinion in Plant Biology · doi:10.1016/j.pbi.2004.01.007 · Cited by 634
Oral Immunization with a Recombinant Bacterial Antigen Produced in Transgenic Plants
Haq, T. A., Mason, H. S., Clements, J. D., & Arntzen, C. J. (1995) · Science · doi:10.1126/science.7732379 · Cited by 622
Transgenic plants as factories for biopharmaceuticals
Giddings, G., Allison, G., Brooks, D., & Carter, A. (2000) · Nature Biotechnology · doi:10.1038/81132 · Cited by 582
Magnifection?a new platform for expressing recombinant vaccines in plants
GLEBA, Y., KLIMYUK, V, & MARILLONNET, S. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.006 · Cited by 441
Viral vectors for the expression of proteins in plants
Gleba, Y., Klimyuk, V., & Marillonnet, S. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.03.002 · Cited by 435
Shaaltiel, Y., Bartfeld, D., Hashmueli, S., Baum, G., Brill‐Almon, E., Galili, G., Dym, O., Boldin‐Adamsky, S. A., Silman, I., Sussman, J. L., et al. (2007) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2007.00263.x · Cited by 425
Plant‐specific glycosylation patterns in the context of therapeutic protein production
Gomord, V., Fitchette, A., Menu‐Bouaouiche, L., Saint‐Jore‐Dupas, C., Plasson, C., Michaud, D., & Faye, L. (2010) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2009.00497.x · Cited by 418
Daniell, H., Lee, S.-B., Panchal, T., & Wiebe, P. O. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4921 · Cited by 398
A plant‐derived edible vaccine against hepatitis B virus
Kapusta, J., Modelska, A., Figlerowicz, M., Pniewski, T., Letellier, M., Lisowa, O., Yusibov, V., Koprowski, H., Plucienniczak, A., & Legocki, A. B. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.13.1796 · Cited by 386
D’Aoust, M., Couture, M. M. ‐., Charland, N., Trépanier, S., Landry, N., Ors, F., & Vézina, L. (2010) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2009.00496.x · Cited by 371
Immunogenicity in humans of an edible vaccine for hepatitis B
Thanavala, Y., Mahoney, M., Pal, S., Scott, A., Richter, L., Natarajan, N., Goodwin, P., Arntzen, C. J., & Mason, H. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409899102 · Cited by 290
D’Aoust, M., Lavoie, P., Couture, M. M. ‐., Trépanier, S., Guay, J., Dargis, M., Mongrand, S., Landry, N., Ward, B. J., & Vézina, L. (2008) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2008.00384.x · Cited by 279
Expression of the Rabies Virus Glycoprotein in Transgenic Tomatoes
McGarvey, P. B., Hammond, J., Dienelt, M. M., Hooper, D. C., Fu, Z. F., Dietzschold, B., Koprowski, H., & Michaels, F. H. (1995) · Nature Biotechnology · doi:10.1038/nbt1295-1484 · Cited by 275
McCormick, A. A., Kumagai, M. H., Hanley, K., Turpen, T. H., Hakim, I., Grill, L. K., Tusé, D., Levy, S., & Levy, R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.703 · Cited by 275
Malaria Epitopes Expressed on the surface of Recombinant Tobacco Mosaic Virus
Turpen, T. H., Reinl, S. J., Charoenvit, Y., Hoffman, S. L., Fallarme, V., & Grill, L. K. (1995) · Nature Biotechnology · doi:10.1038/nbt0195-53 · Cited by 274
Plants as bioreactors: Recent developments and emerging opportunities
Sharma, A. K., & Sharma, M. K. (2009) · Biotechnology Advances · doi:10.1016/j.biotechadv.2009.06.004 · Cited by 251
Expression of tetanus toxin Fragment C in tobacco chloroplasts
Tregoning, J. S. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg221 · Cited by 242
Maclean, J. M., Koekemoer, M., Olivier, A. J., Stewart, D., Hitzeroth, I. I., Rademacher, T., Fischer, R., Williamson, A., & Rybicki, E. P. (2007) · Journal of General Virology · doi:10.1099/vir.0.82718-0 · Cited by 228
Self-citationKoya, V., Moayeri, M., Leppla, S. H., & Daniell, H. (2005) · Infection and Immunity · doi:10.1128/iai.73.12.8266-8274.2005 · Cited by 218
Plant-produced vaccines: promise and reality
Rybicki, E. P. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2008.10.002 · Cited by 204
Self-citationProduction of Human Papillomavirus Type 16 Virus-Like Particles in Transgenic Plants
Biemelt, S., Sonnewald, U., Galmbacher, P., Willmitzer, L., & Müller, M. (2003) · Journal of Virology · doi:10.1128/jvi.77.17.9211-9220.2003 · Cited by 190
Factors effecting expression of vaccines in microalgae
Surzycki, R., Greenham, K., Kitayama, K., Dibal, F., Wagner, R., Rochaix, J.-D., Ajam, T., & Surzycki, S. (2009) · Biologicals · doi:10.1016/j.biologicals.2009.02.005 · Cited by 185
McCormick, A. A., Reddy, S., Reinl, S. J., Cameron, T. I., Czerwinkski, D. K., Vojdani, F., Hanley, K. M., Garger, S. J., White, E. L., Novak, J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803636105 · Cited by 185
Sun, M., Qian, K., Su, N., Chang, H., Liu, J., & Shen, G. (2003) · Biotechnology Letters · doi:10.1023/a:1024140114505 · Cited by 184
High‐yield expression of a viral peptide animal vaccine in transgenic tobacco chloroplasts
Molina, A., Hervás‐Stubbs, S., Daniell, H., Mingo‐Castel, A. M., & Veramendi, J. (2004) · Plant Biotechnology Journal · doi:10.1046/j.1467-7652.2004.00057.x · Cited by 181
Production of biopharmaceuticals and vaccines in plants via the chloroplast genome
Daniell, H. (2006) · Biotechnology Journal · doi:10.1002/biot.200600145 · Cited by 178
Watson, J., Koya, V., Leppla, S. H., & Daniell, H. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.01.069 · Cited by 172
Sandhu, J. S., Krasnyanski, S. F., Domier, L. L., Korban, S. S., Osadjan, M. D., & Buetow, D. E. (2000) · Transgenic Research · doi:10.1023/a:1008979525909 · Cited by 153
Corn as a production system for human and animal vaccines
Streatfield, S. J. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00605-9 · Cited by 135
Elite control of HIV infection: implications for vaccine design
Baker, B. M., Block, B. L., Rothchild, A. C., & Walker, B. D. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712590802571928 · Cited by 125
Expression of human antibodies in eukaryotic micro-algae
Mayfield, S. P., & Franklin, S. E. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.11.013 · Cited by 117
Fischer, R., Schumann, D., Zimmermann, S., Drossard, J., Sack, M., & Schillberg, S. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00435.x · Cited by 116
High-level expression of the HIV-1 Pr55gag polyprotein in transgenic tobacco chloroplasts
Scotti, N., Alagna, F., Ferraiolo, E., Formisano, G., Sannino, L., Buonaguro, L., Stradis, A. D., Vitale, A., Monti, L. M., Grillo, S., et al. (2009) · Planta · doi:10.1007/s00425-009-0898-2 · Cited by 106
Fischer, R., Liao, Y., & Drossard, J. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00058-7 · Cited by 100
Expression of the Human Hepatitis B Virus Large Surface Antigen Gene in Transgenic Tomato Plants
Lou, X.-M., Yao, Q., Zhang, Z., Peng, R., Xiong, A., & Wang, H.-K. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00321-06 · Cited by 99
Lacasse, P., Denis, J., Lapointe, R., Leclerc, D., & Lamarre, A. (2007) · Journal of Virology · doi:10.1128/jvi.01811-07 · Cited by 92
Franconi, R., Bonito, P. D., Dibello, F., Accardi, L., Muller, A., Cirilli, A., Simeone, P., Donà, M. G., Venuti, A., & Giorgi, C. (2002) · PubMed · Cited by 92
Lenzi, P., Scotti, N., Alagna, F., Tornesello, M. L., Pompa, A., Vitale, A., Stradis, A. D., Monti, L. M., Grillo, S., Buonaguro, L., et al. (2008) · Transgenic Research · doi:10.1007/s11248-008-9186-3 · Cited by 91
Durrani, Z., McInerney, T. L., McLain, L., Jones, T. D., Bellaby, T., Brennan, F. R., & Dimmock, N. J. (1998) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00145-8 · Cited by 88
Lico, C., Mancini, C., Italiani, P., Betti, C., Boraschi, D., Benvenuto, E., & Baschieri, S. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.045 · Cited by 87
A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs
Matoba, N., Magérus, A., Geyer, B. C., Zhang, Y., Muralidharan, M., Alfsen, A., Arntzen, C. J., Bomsel, M., & Mor, T. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405297101 · Cited by 86
McCormick, A. A., Corbo, T. A., Wykoff-Clary, S., Nguyen, L. V.-H., Smith, M. L., Palmer, K. E., & Pogue, G. P. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.003 · Cited by 85
Gerber, S., Lane, C., Brown, D. M., Lord, E. M., DiLorenzo, M., Clements, J. D., Rybicki, E. P., Williamson, A., & Rose, R. C. (2001) · Journal of Virology · doi:10.1128/jvi.75.10.4752-4760.2001 · Cited by 85
Self-citationShchelkunov, S. N., Salyaev, R. K., Pozdnyakov, S. G., Rekoslavskaya, N. I., Ae, N., Ryzhova, T. S., Sumtsova, V. M., Pakova, N. V., Mishutina, U. O., Копытина, Т. В., et al. (2006) · Biotechnology Letters · doi:10.1007/s10529-006-9028-4 · Cited by 83
Genetically engineered Tobacco mosaic virus as nanoparticle vaccines
McCormick, A. A., & Palmer, K. E. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.1.33 · Cited by 78
Chebolu, S., & Daniell, H. (2007) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2006.00234.x · Cited by 75
de la Rosa, G. P., Monroy, A., Mora‐García, M. D. L., Reynaga‐Peña, C. G., Hernández‐Montes, J., Weiss‐Steider, B., & Gómez-Lim, M. Á. (2009) · Virology Journal · doi:10.1186/1743-422x-6-2 · Cited by 72
Plant-Based Oral Vaccines: Results of Human Trials
Tacket, C. O. (2009) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-70868-1_6 · Cited by 64
Takaiwa, F. (2007) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2006.11.001 · Cited by 52
Bethencourt, V. (2009) · Nature Biotechnology · doi:10.1038/nbt0809-681a · Cited by 51 · cited 2×
“A later report (Bethencourt, 2009) states that ‘The US Food and Drug Administration (FDA) has contacted rival manufacturers Shire of Basingstoke, UK, and Carmiel, Israel-based Protalix, who have enzyme replacement therapies for Gaucher disease in clinical trials, to file treatment protocols, which…”
BackgroundRamírez, Y. J. P., Tasciotti, E., Gutiérrez‐Ortega, A., Donayre-Torres, A. J., Olivera-Flores, M. T. D. J., Giacca, M., & Gómez-Lim, M. Á. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00028-07 · Cited by 49
Siripornadulsil, S., Dabrowski, K. R., & Sayre, R. T. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-75532-8_11 · Cited by 44
Jaffray, A. E., Shephard, E., Harmelen, J. H. V., Williamson, C. E., Williamson, A., & Rybicki, E. P. (2004) · Journal of General Virology · doi:10.1099/vir.0.19396-0 · Cited by 39
Self-citationDevelopment of oral vaccines for human use.
Ar, F. (2000) · PubMed · Cited by 37
Halsey, R. J., Tanzer, F. L., Meyers, A. E., Pillay, S., Lynch, A. G., Shephard, E., Williamson, A., & Rybicki, E. P. (2008) · Virus Research · doi:10.1016/j.virusres.2008.01.012 · Cited by 30
Self-citationSingh, N. D., Ding, Y., & Daniell, H. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-407-0_10 · Cited by 28
Novel pathways for glycoprotein import into chloroplasts
Faye, L. J.-Y., & Daniell, H. (2006) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2006.00188.x · Cited by 24
Chloroplast Genetic Engineering Via Organogenesis or Somatic Embryogenesis
Dhingra, A., & Daniell, H. (2006) · Humana Press eBooks · doi:10.1385/1-59745-003-0:245 · Cited by 24
Cited by
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Green Synthesis of Metallic Nanoparticles via Biological Entities
Shah, M., Fawcett, D., Sharma, S., Tripathy, S., & Poinern, G. (2015) · Materials · doi:10.3390/ma8115377 · Cited by 1,292
Construction and Characterization of Virus-Like Particles: A Review
Zeltins, A. (2013) · Molecular Biotechnology · doi:10.1007/s12033-012-9598-4 · Cited by 478
Design of virus-based nanomaterials for medicine, biotechnology, and energy
Wen, A. M., & Steinmetz, N. F. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00287g · Cited by 379
Advances in plant molecular farming
Obembe, O. O., Popoola, J. O., Leelavathi, S., & Reddy, S. V. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2010.11.004 · Cited by 276
Metadata
- Authors
- Rybicki, E. P.
- Venue
- Plant Biotechnology Journal
- Publisher
- Wiley
- Published
- 2010-05-09
- Volume
- 8
- Issue
- 5
- Pages
- 620-637
- ISSN
- 1467-7644 (ISSN-L)
- 1467-7652
- OpenAlex
- W2149138353
- Cited by
- 334
- References
- 60
- FWCI
- 28.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.